Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.
Shoaibi A, Lloyd PC, Wong HL, Clarke TC, Chillarige Y, Do R, Hu M, Jiao Y, Kwist A, Lindaas A, Matuska K, McEvoy R, Ondari M, Parulekar S, Shi X, Wang J, Lu Y, Obidi J, Zhou CK, Kelman JA, Forshee RA, Anderson SA.
Shoaibi A, et al. Among authors: lindaas a.
Vaccine. 2023 Jul 19;41(32):4666-4678. doi: 10.1016/j.vaccine.2023.06.014. Epub 2023 Jun 14.
Vaccine. 2023.
PMID: 37344261
Free PMC article.